Haemonetics Corp. (HAE)
118.28
-3.01
(-2.48%)
USD |
NYSE |
Oct 16, 16:00
118.38
+0.10
(+0.08%)
Pre-Market: 20:00
Haemonetics Market Cap : 5.378B for Oct. 16, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 16, 2026 | 5.378B |
| October 15, 2026 | 5.515B |
| October 14, 2026 | 5.507B |
| October 13, 2026 | 5.535B |
| October 12, 2026 | 5.550B |
| October 09, 2026 | 5.397B |
| October 08, 2026 | 5.432B |
| October 07, 2026 | 4.625B |
| October 06, 2026 | 4.707B |
| October 05, 2026 | 4.760B |
| October 02, 2026 | 4.760B |
| October 01, 2026 | 4.746B |
| September 30, 2026 | 4.788B |
| September 29, 2026 | 4.811B |
| September 28, 2026 | 4.810B |
| September 25, 2026 | 4.788B |
| September 24, 2026 | 4.820B |
| September 23, 2026 | 4.857B |
| September 22, 2026 | 4.935B |
| September 21, 2026 | 4.944B |
| September 18, 2026 | 4.929B |
| September 17, 2026 | 4.893B |
| September 16, 2026 | 4.831B |
| September 15, 2026 | 4.829B |
| September 14, 2026 | 4.834B |
| Date | Value |
|---|---|
| September 11, 2026 | 4.669B |
| September 10, 2026 | 4.595B |
| September 09, 2026 | 4.691B |
| September 08, 2026 | 4.676B |
| September 04, 2026 | 4.680B |
| September 03, 2026 | 4.677B |
| September 02, 2026 | 4.680B |
| September 01, 2026 | 4.636B |
| August 31, 2026 | 4.687B |
| August 28, 2026 | 4.727B |
| August 27, 2026 | 4.774B |
| August 26, 2026 | 4.847B |
| August 25, 2026 | 4.925B |
| August 24, 2026 | 4.929B |
| August 21, 2026 | 4.947B |
| August 20, 2026 | 4.921B |
| August 19, 2026 | 4.930B |
| August 18, 2026 | 4.759B |
| August 17, 2026 | 4.105B |
| August 14, 2026 | 4.129B |
| August 13, 2026 | 4.110B |
| August 12, 2026 | 4.153B |
| August 11, 2026 | 3.966B |
| August 10, 2026 | 3.938B |
| August 07, 2026 | 3.994B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Globus Medical, Inc. | 10.30B |
| Abbott Laboratories | 181.50B |
| ICU Medical, Inc. | 4.076B |
| Merit Medical Systems, Inc. | 5.326B |
| Teleflex, Inc. | 5.527B |
Market Cap Related Metrics
| PE Ratio | 57.69 |
| PS Ratio | 4.081 |
| Price to Book Value | 6.425 |
| Price to Free Cash Flow | 18.95 |
| Price | 118.28 |
| Earnings Yield | 1.73% |
| Operating PE Ratio | 22.22 |
| Normalized PE Ratio | 35.39 |